InsiderTrades.com logo
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

YMTX Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 12.45%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Yumanity Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Yumanity Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Yumanity Therapeutics Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 10/24/2024 01:00 AM ET

This chart shows the closing price history over time for YMTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

Yumanity Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/2/2022Michael D WyzgaInsiderSell3,116$1.69$5,266.0413,997View SEC Filing Icon  
12/2/2022Richard PetersCEOSell10,890$1.69$18,404.1090,028View SEC Filing Icon  
7/5/2022Richard PetersCEOSell4,584$1.85$8,480.40100,918View SEC Filing Icon  
6/3/2022Devin Whittemore SmithSVPSell2,923$1.19$3,478.3717,077View SEC Filing Icon  
6/3/2022Marie EpsteinInsiderSell1,806$1.19$2,149.1410,859View SEC Filing Icon  
6/3/2022Richard PetersCEOSell10,206$1.19$12,145.14105,502View SEC Filing Icon  
3/28/2022Richard PetersCEOSell10,715$1.85$19,822.75View SEC Filing Icon  
2/3/2022Paulash MohsenInsiderSell1,958$1.83$3,583.14View SEC Filing Icon  
See Full Table
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

SEC Filings (Institutional Ownership Changes) for Yumanity Therapeutics (NASDAQ:YMTX)

25.10% of Yumanity Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at YMTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Yumanity Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/12/2022Ikarian Capital LLC104,392$0.19M0.0%-55.8%0.962%Search for SEC Filing on Google Icon
8/1/2022Monaco Asset Management SAM50,000$91K0.0%N/A0.461%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC75,928$0.22M0.0%+272.7%0.737%Search for SEC Filing on Google Icon
11/17/2021Altium Capital Management LP196,000$2.02M0.5%+58.5%1.902%Search for SEC Filing on Google Icon
11/16/2021Bain Capital Public Equity Management II LLC27,972$0.29M0.0%-8.3%0.271%Search for SEC Filing on Google Icon
11/15/2021Sphera Funds Management LTD.75,836$0.78M0.1%-34.2%0.736%Search for SEC Filing on Google Icon
11/15/2021Ovata Capital Management Ltd18,700$0.19M0.1%N/A0.181%Search for SEC Filing on Google Icon
11/15/2021Ensign Peak Advisors Inc33,840$0.35M0.0%N/A0.328%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC35,919$0.37M0.0%N/A0.349%Search for SEC Filing on Google Icon
11/12/2021Stonepine Capital Management LLC481,692$4.97M2.3%+9.0%4.674%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC10,300$0.11M0.0%N/A0.100%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.69,905$0.72M0.0%+6.9%0.678%Search for SEC Filing on Google Icon
8/17/2021Sphera Funds Management LTD.115,298$1.34M0.1%-44.7%1.130%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC304,475$0.17M0.0%+2,000.1%2.984%Search for SEC Filing on Google Icon
8/16/2021Redmile Group LLC59,487$0.69M0.0%-90.3%0.583%Search for SEC Filing on Google Icon
8/16/2021Diametric Capital LP20,939$0.24M0.2%N/A0.205%Search for SEC Filing on Google Icon
8/13/2021Altium Capital Management LP123,693$1.44M0.3%+13.8%1.212%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC21,024$0.24M0.0%+16.1%0.206%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP10,369$0.12M0.0%N/A0.102%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC47,381$43K0.0%N/A1.816%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC47,381$43K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.208,609$3.78M0.3%+59.9%0.000%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC219,470$3.97M0.1%+65.6%0.000%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC18,108$0.33M0.0%+9.6%0.000%Search for SEC Filing on Google Icon
5/12/2021Pura Vida Investments LLC68,853$1.25M0.0%N/A0.000%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.64,431$1.17M0.0%+18.3%0.000%Search for SEC Filing on Google Icon
2/16/2021HarbourVest Partners LLC22,030$0.38M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/12/2021Stonepine Capital Management LLC108,847$1.85M1.4%N/A0.000%Search for SEC Filing on Google Icon
2/12/2021Ikarian Capital LLC132,514$2.25M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/11/2021Artal Group S.A.217,391$3.70M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC18,349$0.31M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN2,898$50K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.54,469$0.93M0.0%N/A0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Yumanity Therapeutics logo
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration. Its lead program is YTX-7739, a novel small molecule that is in Phase I clinical trial for the treatment of Parkinson's disease and related disorders of a-synuclein. The company is also developing YTX-9184, which is in preclinical studies to treat neurological disorders. Yumanity Therapeutics Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Read More on Yumanity Therapeutics

Today's Range

Now: N/A

50 Day Range

MA: $0.68
Low: $0.56
High: $1.89

52 Week Range

Now: N/A

Volume

6,790 shs

Average Volume

473,083 shs

Market Capitalization

$7.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.32

Who are the company insiders with the largest holdings of Yumanity Therapeutics?

Yumanity Therapeutics' top insider shareholders include:
  1. Richard Peters (CEO)
  2. Michael D Wyzga (Insider)
Learn More about top insider investors at Yumanity Therapeutics.
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.